These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17900987)

  • 1. 'Sensing' autoimmunity in type 1 diabetes.
    Tsui H; Razavi R; Chan Y; Yantha J; Dosch HM
    Trends Mol Med; 2007 Oct; 13(10):405-13. PubMed ID: 17900987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRPV1+ sensory neurons control beta cell stress and islet inflammation in autoimmune diabetes.
    Razavi R; Chan Y; Afifiyan FN; Liu XJ; Wan X; Yantha J; Tsui H; Tang L; Tsai S; Santamaria P; Driver JP; Serreze D; Salter MW; Dosch HM
    Cell; 2006 Dec; 127(6):1123-35. PubMed ID: 17174891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet glia, neurons, and beta cells.
    Tsui H; Winer S; Chan Y; Truong D; Tang L; Yantha J; Paltser G; Dosch HM
    Ann N Y Acad Sci; 2008 Dec; 1150():32-42. PubMed ID: 19120264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulation and regeneration of islet Beta cells by cytokines in autoimmune type 1 diabetes.
    Singh B; Nikoopour E; Huszarik K; Elliott JF; Jevnikar AM
    J Interferon Cytokine Res; 2011 Oct; 31(10):711-9. PubMed ID: 21851268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysrulation of T cell peripheral tolerance in type 1 diabetes.
    Tisch R; Wang B
    Adv Immunol; 2008; 100():125-49. PubMed ID: 19111165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
    Serreze DV; Marron MP; Dilorenzo TP
    Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides.
    Reddy S; Cheung CC; Chai RC; Rodrigues JA
    Ann N Y Acad Sci; 2008 Dec; 1150():171-6. PubMed ID: 19120289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological aspects of 'fulminant type 1 diabetes'.
    Nagata M; Moriyama H; Kotani R; Yasuda H; Kishi M; Kurohara M; Hara K; Yokono K
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S99-103. PubMed ID: 17478003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ T cells in type 1 diabetes.
    Tsai S; Shameli A; Santamaria P
    Adv Immunol; 2008; 100():79-124. PubMed ID: 19111164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensory neurons link the nervous system and autoimmune diabetes.
    Bour-Jordan H; Bluestone JA
    Cell; 2006 Dec; 127(6):1097-9. PubMed ID: 17174888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Sensing' the link between type 1 and type 2 diabetes.
    Tsui H; Paltser G; Chan Y; Dorfman R; Dosch HM
    Diabetes Metab Res Rev; 2011 Nov; 27(8):913-8. PubMed ID: 22069284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global gene expression changes in type 1 diabetes: insights into autoimmune response in the target organ and in the periphery.
    Planas R; Pujol-Borrell R; Vives-Pi M
    Immunol Lett; 2010 Oct; 133(2):55-61. PubMed ID: 20708640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexpected functional consequences of xenogeneic transgene expression in beta-cells of NOD mice.
    Leiter EH; Reifsnyder P; Driver J; Kamdar S; Choisy-Rossi C; Serreze DV; Hara M; Chervonsky A
    Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():14-22. PubMed ID: 17919174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of low avidity T cells in the protection against type 1 diabetes: a modeling investigation.
    Khadra A; Santamaria P; Edelstein-Keshet L
    J Theor Biol; 2009 Jan; 256(1):126-41. PubMed ID: 18950644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-modifying immunotherapy for the management of autoimmune diabetes.
    Castro CN; Barcala Tabarrozi AE; Noguerol MA; Liberman AC; Dewey RA; Arzt E; Morelli AE; Perone MJ
    Neuroimmunomodulation; 2010; 17(3):173-6. PubMed ID: 20134195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Of mice and men: use of animal models to identify possible interventions for the prevention of autoimmune type 1 diabetes in humans.
    Serreze DV; Chen YG
    Trends Immunol; 2005 Nov; 26(11):603-7. PubMed ID: 16140038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes.
    Shieh SJ; Chou FC; Yu PN; Lin WC; Chang DM; Roffler SR; Sytwu HK
    J Immunol; 2009 Aug; 183(4):2277-85. PubMed ID: 19635924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons on autoimmune diabetes from animal models.
    Yang Y; Santamaria P
    Clin Sci (Lond); 2006 Jun; 110(6):627-39. PubMed ID: 16689681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic islet cell phenotype and endocrine function throughout diabetes development in non-obese diabetic mice.
    Kornete M; Beauchemin H; Polychronakos C; Piccirillo CA
    Autoimmunity; 2013 Jun; 46(4):259-68. PubMed ID: 23256897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes.
    Yang Z; Chen M; Carter JD; Nunemaker CS; Garmey JC; Kimble SD; Nadler JL
    Biochem Biophys Res Commun; 2006 Jun; 344(3):1017-22. PubMed ID: 16643856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.